U.S. flag

An official website of the United States government

NM_005591.4(MRE11):c.1480G>A (p.Glu494Lys) AND not provided

Germline classification:
Conflicting interpretations of pathogenicity (4 submissions)
Last evaluated:
Sep 13, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000114896.31

Allele description [Variation Report for NM_005591.4(MRE11):c.1480G>A (p.Glu494Lys)]

NM_005591.4(MRE11):c.1480G>A (p.Glu494Lys)

Gene:
MRE11:MRE11 homolog, double strand break repair nuclease [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q21
Genomic location:
Preferred name:
NM_005591.4(MRE11):c.1480G>A (p.Glu494Lys)
HGVS:
  • NC_000011.10:g.94459428C>T
  • NG_007261.1:g.39447G>A
  • NM_001330347.2:c.1480G>A
  • NM_005590.4:c.1480G>A
  • NM_005591.4:c.1480G>AMANE SELECT
  • NP_001317276.1:p.Glu494Lys
  • NP_005581.2:p.Glu494Lys
  • NP_005582.1:p.Glu494Lys
  • NP_005582.1:p.Glu494Lys
  • LRG_85t1:c.1480G>A
  • LRG_85:g.39447G>A
  • LRG_85p1:p.Glu494Lys
  • NC_000011.8:g.93832242C>T
  • NC_000011.9:g.94192594C>T
  • NM_005591.3:c.1480G>A
  • p.E494K
Protein change:
E494K
Links:
dbSNP: rs104895016
NCBI 1000 Genomes Browser:
rs104895016
Molecular consequence:
  • NM_001330347.2:c.1480G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005590.4:c.1480G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005591.4:c.1480G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000148791Harris Lab, University of Minnesota
no classification provided
not providedunknownnot provided

SCV000614120Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics Criteria)
Likely benign
(Jul 15, 2020)
unknownclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV001248580CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Uncertain significance
(Aug 1, 2019)
germlineclinical testing

Citation Link,

SCV001872700GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Uncertain significance
(Sep 13, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing
not providedunknownnot providednot providednot providednot provided1not providedliterature only
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.

Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P, Olson JE, Godwin AK, Pankratz VS, Olswold C, Slettedahl S, Hallberg E, Guidugli L, Davila JI, Beckmann MW, Janni W, Rack B, Ekici AB, Slamon DJ, Konstantopoulou I, Fostira F, Vratimos A, et al.

J Clin Oncol. 2015 Feb 1;33(4):304-11. doi: 10.1200/JCO.2014.57.1414. Epub 2014 Dec 1.

PubMed [citation]
PMID:
25452441
PMCID:
PMC4302212

Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations.

Caminsky NG, Mucaki EJ, Perri AM, Lu R, Knoll JH, Rogan PK.

Hum Mutat. 2016 Jul;37(7):640-52. doi: 10.1002/humu.22972. Epub 2016 Mar 18.

PubMed [citation]
PMID:
26898890
See all PubMed Citations (3)

Details of each submission

From Harris Lab, University of Minnesota, SCV000148791.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot providednot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownnot provided1not providednot providednot providednot providednot providednot provided

From Athena Diagnostics, SCV000614120.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV001248580.26

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

From GeneDx, SCV001872700.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Observed in individuals with breast cancer and present only in controls in a study of common variable immunodeficiency (CVID) (PMID: 26898890, 25452441, 20805886); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25452441, 26898890, 25344691, 20805886)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024